Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized study of bendamustine versus Treatment of Physician's Choice in rituximab-refractory indolent B-cell non-Hodgkin lymphoma
2010-022102-41Phase 3Terminated
- Sponsor
- Mundipharma Research
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bendamustine in low-grade B-cell lymphoma and non-Hodgkin lymphoma (NHL) (2 arms), sponsored by Mundipharma Research. Started Dec 2010; status: terminated.
02
Drugs
bendamustine
03
Conditions
low-grade B-cell lymphomanon-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on 2010-022102-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022102-41.